ArticleWorld journal of urology2026
Editorial: future of ureteral stents: what do we need? a pearls opinion.
Article in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ureteral stents, introduced in 1960s, are essential for managing upper urinary tract pathologies, maintaining ureteral patency in conditions like obstruction, trauma and post-surgery. However, stent-related symptoms (SRS) including pain, dysuria, and urinary frequency, remain a significant clinical challenge. Advances in stent design, biomaterials, drug-eluting catheters and biodegradable options aim to reduce SRS and complications like encrustation and infections. Despite this improvements, the ideal stent has yet to be achieved. The future of stent therapy lies in personalized approaches, aided by artificial intelligence and machine learning, and will focus on reducing morbidity while enhancing patient outcomes and quality of life.
Indexed as
Identifiers
42053868What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.